Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.97 -0.05 (-4.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) recorded EBIT of -$3.34 million in Q2 2026, compared with -$3.73 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026) Analysis & Trends

On a TTM basis, Cadrenal Therapeutics' EBIT came in at -$12 million as of Jun 30, 2026; for FY2023, it was -$7.63 million.

  • Across earlier years, EBIT came in at -$2.7 million in FY2022.
  • The Q2 2026 figure is the highest quarterly EBIT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.43 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.27 Bn
10 Cadrenal Therapeutics 2.85 Mn -9.77 Mn - -3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Jun 30, 2025 -3.73 Mn
Sep 30, 2024 -2.46 Mn
Jun 30, 2024 -2.47 Mn
Mar 31, 2024 -1.76 Mn
Dec 31, 2023 -1.26 Mn
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -1.03 Mn
Mar 31, 2023 -4.20 Mn
Dec 31, 2022 -1.08 Mn
Sep 30, 2022 -972,791.00
Jun 30, 2022 -482,347.00
Mar 31, 2022 -170,521.00
API Access

Cadrenal Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CVKD&period=max&api_key=YOUR_API_KEY